Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis. Radlinger B, Ress C, Folie S, Salzmann K, et al. Diabetologia 2023;66:754-767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Radlinger B, Ress C, Folie S, Salzmann K, et al. Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis. Diabetologia 2023;66:754-767.
PMID: 36525084